Xiangmei Wu

1.1k total citations
37 papers, 890 citations indexed

About

Xiangmei Wu is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Xiangmei Wu has authored 37 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Xiangmei Wu's work include Epigenetics and DNA Methylation (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Polysaccharides and Plant Cell Walls (4 papers). Xiangmei Wu is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Polysaccharides and Plant Cell Walls (4 papers). Xiangmei Wu collaborates with scholars based in China, United States and France. Xiangmei Wu's co-authors include Jing Sun, Hui Dai, Xiao‐Ming Gao, Pengfei Tu, Liang Li, Shen Li, Mengjun Liu, Zhihui Zhao, Peng‐Fei Tu and Nirmal D. Pugh and has published in prestigious journals such as Neuroscience, Gene and Food Research International.

In The Last Decade

Xiangmei Wu

37 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangmei Wu China 18 470 242 140 108 99 37 890
Su Jung Hwang South Korea 16 541 1.2× 163 0.7× 126 0.9× 119 1.1× 141 1.4× 44 1.3k
Qiaoyan Zhang China 18 463 1.0× 239 1.0× 145 1.0× 69 0.6× 136 1.4× 48 1.1k
Ming‐Jyh Sheu Taiwan 22 530 1.1× 187 0.8× 66 0.5× 93 0.9× 192 1.9× 57 1.1k
Huỳnh Kỳ Malaysia 18 408 0.9× 175 0.7× 107 0.8× 148 1.4× 37 0.4× 44 885
Yavuz Dodurga Türkiye 22 656 1.4× 133 0.5× 91 0.7× 248 2.3× 144 1.5× 79 1.3k
Rashmeet K. Reen United States 20 338 0.7× 110 0.5× 78 0.6× 121 1.1× 87 0.9× 33 1.1k
Deborah Fratantonio Italy 17 502 1.1× 101 0.4× 59 0.4× 183 1.7× 56 0.6× 24 986
Fu Peng China 22 772 1.6× 197 0.8× 122 0.9× 320 3.0× 96 1.0× 55 1.4k
Yann Schneider France 13 577 1.2× 106 0.4× 136 1.0× 99 0.9× 66 0.7× 16 1.1k
Young-Beob Yu South Korea 14 419 0.9× 147 0.6× 111 0.8× 55 0.5× 182 1.8× 49 1.0k

Countries citing papers authored by Xiangmei Wu

Since Specialization
Citations

This map shows the geographic impact of Xiangmei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangmei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangmei Wu more than expected).

Fields of papers citing papers by Xiangmei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangmei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangmei Wu. The network helps show where Xiangmei Wu may publish in the future.

Co-authorship network of co-authors of Xiangmei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangmei Wu. A scholar is included among the top collaborators of Xiangmei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangmei Wu. Xiangmei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mengxue, Yongqin Wang, Xiangmei Wu, et al.. (2024). KIAA0753 enhances osteoblast differentiation suppressed by diabetes. Journal of Cellular and Molecular Medicine. 28(17). e70035–e70035. 1 indexed citations
2.
Wu, Xiangmei, et al.. (2024). Mitosis targeting in non-small lung cancer cells by inhibition of PAD4. Heliyon. 10(6). e27313–e27313. 2 indexed citations
3.
Wang, Changdong, et al.. (2023). PDGF-BB/PDGFRβ induces tumour angiogenesis via enhancing PKM2 mediated by the PI3K/AKT pathway in Wilms’ tumour. Medical Oncology. 40(8). 240–240. 11 indexed citations
4.
Liu, Jie, Qingfeng Cheng, Xiangmei Wu, et al.. (2022). Icariin Treatment Rescues Diabetes Induced Bone Loss via Scavenging ROS and Activating Primary Cilia/Gli2/Osteocalcin Signaling Pathway. Cells. 11(24). 4091–4091. 18 indexed citations
5.
Guo, Jiaqi, et al.. (2021). PDGFRβ modulates aerobic glycolysis in osteosarcoma HOS cells via the PI3K/AKT/mTOR/c-Myc pathway. Biochemistry and Cell Biology. 100(1). 75–84. 12 indexed citations
6.
Peng, Yan, et al.. (2018). Influence of glucose transporter 1 activity inhibition on neuroblastoma in vitro. Gene. 689. 11–17. 24 indexed citations
7.
Xu, Xinyu, Yong Gu, Yun Shi, et al.. (2015). Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes. Vaccine. 34(6). 854–862. 20 indexed citations
8.
Wu, Xiangmei, Xing Liu, Qing-fang Jiao, et al.. (2014). Cytotoxic T Lymphocytes Elicited by Dendritic Cell-Targeted Delivery of Human Papillomavirus Type-16 E6/E7 Fusion Gene Exert Lethal Effects on CaSki Cells. Asian Pacific Journal of Cancer Prevention. 15(6). 2447–2451. 7 indexed citations
9.
Yang, Qinglin, Xiangmei Wu, Jing Sun, Jing Cui, & Liang Li. (2014). Epigenetic Features Induced by Ischemia-Hypoxia in Cultured Rat Astrocytes. Molecular Neurobiology. 53(1). 436–445. 14 indexed citations
10.
Wu, Xiangmei, Xinyu Xu, Zhixiao Wang, et al.. (2012). Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays. Autoimmunity. 45(2). 176–185. 13 indexed citations
11.
Huang, He, Zailin Yang, Xiangmei Wu, et al.. (2012). Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance. Journal of Antimicrobial Chemotherapy. 67(12). 2825–2832. 61 indexed citations
13.
Nielsen, Claus Henrik, Premalatha Balachandran, Ole Christensen, et al.. (2010). Enhancement of Natural Killer Cell Activity in Healthy Subjects by Immulina®, aSpirulinaExtract Enriched for Braun-Type Lipoproteins. Planta Medica. 76(16). 1802–1808. 39 indexed citations
14.
Han, Xiaoqiang, Xiangmei Wu, Xingyun Chai, et al.. (2010). Isolation, characterization and immunological activity of a polysaccharide from the fruit bodies of an edible mushroom, Sarcodon aspratus (Berk.) S. Ito.. Food Research International. 44(1). 489–493. 54 indexed citations
15.
Wu, Xiangmei, Zheng Fu, Xiaojun Wang, & Shen Wang. (2010). Identification of differential proteins in colon cancer SW480 cells with HIF1-α silence by proteome analysis. Neoplasma. 57(4). 299–305. 8 indexed citations
16.
Wu, Xiangmei, Xing Liu, Youquan Bu, et al.. (2009). RNAi-mediated silencing of the Bmi-1 gene causes growth inhibition and enhances doxorubicin-induced apoptosis in MCF-7 cells. Genetics and Molecular Biology. 32(4). 697–703. 5 indexed citations
17.
Pugh, Nirmal D., Premalatha Balachandran, Xiangmei Wu, et al.. (2008). The majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharides. International Immunopharmacology. 8(7). 1023–1032. 57 indexed citations
18.
Zhao, Zhihui, Jun Li, Xiangmei Wu, et al.. (2006). Structures and immunological activities of two pectic polysaccharides from the fruits of Ziziphus jujuba Mill. cv. jinsixiaozao Hort.. Food Research International. 39(8). 917–923. 107 indexed citations
19.
Wu, Xiangmei, Hui Dai, Lixin Huang, et al.. (2006). A Fructan, from Radix Ophiopogonis, Stimulates the Proliferation of Cultured Lymphocytes:  Structural and Functional Analyses. Journal of Natural Products. 69(9). 1257–1260. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026